Form 4: LeMaitre Vascular CEO George LeMaitre Reports Changes in Beneficial Ownership
SEC Form 4 Filing
George LeMaitre, Chairman and CEO of LeMaitre Vascular, reports transactions involving common stock related to performance share units and dividend equivalent rights.
Summary
- On February 28, 2025, George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, reported changes in his beneficial ownership of the company's common stock.
- These changes involve the acquisition of 1,510 shares upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023.
- Additionally, 11 shares were acquired upon the release of dividend equivalent rights on a one-for-one basis.
- 447 shares were withheld by the issuer to satisfy tax withholding obligations related to the vesting of the PSU award.
- Following these transactions, LeMaitre beneficially owns 1,892,384 shares of LeMaitre Vascular common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common for publicly traded companies.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| December 8, 2023 | Date of grant for the Performance Share Unit (PSU) award. |
| December 3, 2024 | Date of execution for the Limited Power of Attorney. |
| February 28, 2025 | Date of the transactions reported in the Form 4 filing. |
| March 4, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.